Animal models of anxiety disorders

Animal models may be useful in investigating the fundamental mechanisms underlying psychiatric disorders, and may contribute to the development of new medications. A computerized literature search was used to collect studies on recently developed animal models for anxiety disorders. Particular cognitive-affective processes (eg, fear conditioning, control of stereotypic movements, social submissiveness, and trauma sensitization) may be particularly relevant to understanding specific anxiety disorders. Delineation of the phenomenology and psychobiology of these processes in animals leads to a range of useful models of these conditions. These models demonstrate varying degrees of face, construct, and predictive validity.

[1]  M. Mishina,et al.  Lower Sensitivity to Stress and Altered Monoaminergic Neuronal Function in Mice Lacking the NMDA Receptor ε4 Subunit , 2002, The Journal of Neuroscience.

[2]  M. Toth,et al.  The 5-HT(1A) receptor knockout mouse and anxiety. , 2001, Behavioural pharmacology.

[3]  Dan J Stein,et al.  Defining the neuromolecular action of myo-inositol Application to obsessive–compulsive disorder , 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[4]  E. Hollander,et al.  Pharmacotherapy of obsessive‐compulsive disorder: experience with the selective serotonin reuptake inhibitors , 2000, International clinical psychopharmacology.

[5]  R. Yehuda,et al.  Neuroendocrine activity and memory-related impairments in posttraumatic stress disorder , 1998, Development and Psychopathology.

[6]  J. Ballenger Current treatments of the anxiety disorders in adults , 1999, Biological Psychiatry.

[7]  Michael Davis,et al.  Facilitation of Conditioned Fear Extinction by Systemic Administration or Intra-Amygdala Infusions of d-Cycloserine as Assessed with Fear-Potentiated Startle in Rats , 2002, The Journal of Neuroscience.

[8]  M. Brandão,et al.  Dorsolateral and ventral regions of the periaqueductal gray matter are involved in distinct types of fear , 2001, Neuroscience & Biobehavioral Reviews.

[9]  A. Zbrożyna,et al.  Amygdaloid region for defence reactions and its efferent pathway to the brain stem , 1963, The Journal of physiology.

[10]  C. Sánchez Stress-induced vocalisation in adult animals. A valid model of anxiety? , 2003, European journal of pharmacology.

[11]  L. Takahashi,et al.  Antagonism of CRF2 receptors produces anxiolytic behavior in animal models of anxiety , 2001, Brain Research.

[12]  JaneR . Taylor,et al.  An animal model of Tourette's syndrome. , 2002, The American journal of psychiatry.

[13]  J. Kehne,et al.  Anxiolytic effects of buspirone and gepirone in the fear-potentiated startle paradigm , 2004, Psychopharmacology.

[14]  J. Karhu,et al.  Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder: a fractal analysis , 1997, Molecular Psychiatry.

[15]  C. Belzung,et al.  The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. , 2003, European journal of pharmacology.

[16]  Joseph E LeDoux,et al.  Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[17]  Joseph E LeDoux Fear and the brain: where have we been, and where are we going? , 1998, Biological Psychiatry.

[18]  R. Hen,et al.  Altered Emotional States in Knockout Mice Lacking 5-HT1A or 5-HT1B Receptors , 1999, Neuropsychopharmacology.

[19]  C. McDougle,et al.  Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder? , 1990, The Journal of clinical psychiatry.

[20]  D. Treit Animal models for the study of anti-anxiety agents: A review , 1985, Neuroscience & Biobehavioral Reviews.

[21]  H. Westenberg,et al.  Social anxiety disorder and generalized anxiety disorder: serotonergic and dopaminergic neurocircuitry. , 2002, The Journal of clinical psychiatry.

[22]  O. Cameron,et al.  Endocrine, cardiovascular, and behavioral responses to clonidine in patients with panic disorder , 1992, Biological Psychiatry.

[23]  D. Stein,et al.  A neuro-evolutionary approach to the anxiety disorders. , 1997, Journal of anxiety disorders.

[24]  J. Bremner,et al.  Are the neural substrates of memory the final common pathway in posttraumatic stress disorder (PTSD)? , 2002, Journal of affective disorders.

[25]  R. Noyes,et al.  The association of urinary 5-hydroxyindoleacetic acid and vanillylmandelic acid in patients with generalized anxiety. , 1995, Neuropsychobiology.

[26]  G. Richter-Levin Acute and long-term behavioral correlates of underwater trauma — potential relevance to stress and post-stress syndromes , 1998, Psychiatry Research.

[27]  M. Yang,et al.  Environmental enrichment: effects on stereotyped behavior and regional neuronal metabolic activity , 2002, Brain Research.

[28]  S. Orr,et al.  Endogenous opioids, stress induced analgesia, and posttraumatic stress disorder. , 1989, Psychopharmacology bulletin.

[29]  M. Garvey,et al.  Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood , 1999, The Lancet.

[30]  S. Woods,et al.  Effects of the serotonin reuptake inhibitor fluvoxamine on yohimbine-induced anxiety in panic disorder , 1993, Psychiatry Research.

[31]  E. Young,et al.  Differential Regulation of Hippocampal Glucocorticoid Receptors mRNA and Fast Feedback: Relevance to Post‐Traumatic Stress Disorder , 1999, Journal of neuroendocrinology.

[32]  M. Tancer,et al.  Normal urinary free cortisol and postdexamethasone cortisol in social phobia: comparison to normal volunteers. , 1994, Journal of affective disorders.

[33]  J W Mason,et al.  Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. , 1993, The American journal of psychiatry.

[34]  D. Stein,et al.  Hoarding: a review. , 1999, The Israel journal of psychiatry and related sciences.

[35]  Dan J Stein,et al.  Endocrine, cognitive and hippocampal/cortical 5HT1A/2A receptor changes evoked by a time-dependent sensitisation (TDS) stress model in rats , 2003, Brain Research.

[36]  J M Gorman,et al.  Neuroanatomical hypothesis of panic disorder, revised. , 2000, The American journal of psychiatry.

[37]  J. Moreau,et al.  Dorsal periaqueductal gray-induced aversion as a simulation of panic anxiety: Elements of face and predictive validity , 1995, Psychiatry Research.

[38]  M. Brandão,et al.  Acute and Chronic Effects of Gepirone and Fluoxetine in Rats Tested in the Elevated Plus-maze An Ethological Analysis , 2000, Pharmacology Biochemistry and Behavior.

[39]  David L. Walker,et al.  The role of amygdala glutamate receptors in fear learning, fear-potentiated startle, and extinction , 2002, Pharmacology Biochemistry and Behavior.

[40]  J. King,et al.  Genetic predisposition and the development of posttraumatic stress disorder in an animal model , 2001, Biological Psychiatry.

[41]  C. McDougle,et al.  A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. , 2000, Archives of general psychiatry.

[42]  R. Yehuda,et al.  Criteria for rationally evaluating animal models of postraumatic stress disorder , 1993, Biological Psychiatry.

[43]  M. E. Nevins,et al.  Anxiolytic-like effects of N-methyl-D-aspartate-associated glycine receptor ligands in the rat potentiated startle test. , 1993, European journal of pharmacology.

[44]  D. Joel,et al.  Selective Alleviation of Compulsive Lever-Pressing in Rats by D1, but not D2, Blockade: Possible Implications for the Involvement of D1 Receptors in Obsessive–Compulsive Disorder , 2003, Neuropsychopharmacology.

[45]  A. Kelley,et al.  Oral stereotypy induced by amphetamine microinjection into striatum: An anatomical mapping study , 1994, Neuroscience.

[46]  D. Sheehan,et al.  Current concepts in the treatment of panic disorder. , 1999, The Journal of clinical psychiatry.

[47]  J. Gorman,et al.  Uncoupling of the Noradrenergic-Hypothalamic-Pituitary-Adrenal Axis in Panic Disorder Patients , 1995, Neuropsychopharmacology.

[48]  Michael Davis,et al.  Are different parts of the extended amygdala involved in fear versus anxiety? , 1998, Biological Psychiatry.

[49]  Martin H. Teicher,et al.  Plasma norepinephrine and 3-methoxy-4-hydroxyphenylglycol concentrations and severity of depression in combat posttraumatic stress disorder and major depressive disorder , 1998, Biological Psychiatry.

[50]  M. Koch,et al.  Lesions of the central gray block conditioned fear as measured with the potentiated startle paradigm , 1996, Behavioural Brain Research.

[51]  M. Raleigh,et al.  Dominant social status facilitates the behavioral effects of serotonergic agonists , 1985, Brain Research.

[52]  R. Adamec,et al.  Lasting effects on rodent anxiety of a single exposure to a cat , 1993, Physiology & Behavior.

[53]  D. Stein,et al.  Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety. , 2001, The Journal of clinical psychiatry.

[54]  Mark H Lewis,et al.  Selective blockade of spontaneous motor stereotypy via intrastriatal pharmacological manipulation , 2003, Pharmacology Biochemistry and Behavior.

[55]  Michael Davis,et al.  Double Dissociation between the Involvement of the Bed Nucleus of the Stria Terminalis and the Central Nucleus of the Amygdala in Startle Increases Produced by Conditioned versus Unconditioned Fear , 1997, The Journal of Neuroscience.

[56]  David Eilam,et al.  Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder (OCD). , 1998, Behavioral neuroscience.

[57]  Dan J Stein,et al.  Chronic inositol increases striatal D2 receptors but does not modify dexamphetamine-induced motor behavior Relevance to obsessive–compulsive disorder , 2001, Pharmacology Biochemistry and Behavior.

[58]  M. Nader,et al.  Effect of social status on striatal dopamine D2 receptor binding characteristics in cynomolgus monkeys assessed with positron emission tomography , 1998, Synapse.

[59]  C. Nemeroff,et al.  The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies , 2001, Biological Psychiatry.

[60]  S. Swedo,et al.  Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS). , 2001, The international journal of neuropsychopharmacology.

[61]  H. Wittchen The many faces of social anxiety disorder , 2000, International clinical psychopharmacology.

[62]  F. Macciardi,et al.  Association between the dopamine transporter gene and posttraumatic stress disorder , 2002, Molecular Psychiatry.

[63]  C. Stewart,et al.  Antidepressant mechanisms: functional and molecular correlates of excitatory amino acid neurotransmission , 2002, Molecular Psychiatry.

[64]  J. Pendergast,et al.  A Rodent Model of Spontaneous Stereotypy Initial Characterization of Developmental, Environmental, and Neurobiological Factors , 1999, Physiology & Behavior.

[65]  S. File,et al.  Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the rat , 1985, Journal of Neuroscience Methods.

[66]  S. Stahl How psychiatrists can build new therapies for impotence. , 1998, The Journal of clinical psychiatry.

[67]  P. Brown Physiology of startle phenomena. , 1995, Advances in neurology.

[68]  W. Danysz,et al.  Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats , 2002, Neuropharmacology.

[69]  Michael Davis Diazepam and flurazepam: Effects on conditioned fear as measured with the potentiated startle paradigm , 1979, Psychopharmacology.

[70]  R. Ritzmann,et al.  A behavioral animal model of posttraumatic stress disorder featuring repeated exposure to situational reminders , 1996, Biological Psychiatry.

[71]  I. Liberzon,et al.  Stress-restress: Effects on ACTH and fast feedback , 1997, Psychoneuroendocrinology.

[72]  G. Koob,et al.  Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat , 2002, Brain Research.

[73]  H. Szechtman,et al.  Effect of nicotine on quinpirole-induced checking behavior in rats: implications for obsessive-compulsive disorder , 2002, Biological Psychiatry.

[74]  S. Mineka,et al.  Conditioning and ethological models of anxiety disorders: stress-in-dynamic-context anxiety models. , 1996, Nebraska Symposium on Motivation. Nebraska Symposium on Motivation.

[75]  Mark H Lewis,et al.  Dissociation between spontaneously emitted and apomorphine-induced stereotypy in Peromyscus maniculatus bairdii , 2002, Physiology & Behavior.

[76]  C. Pavlides,et al.  Genetic Inactivation of the Serotonin1A Receptor in Mice Results in Downregulation of Major GABAA Receptor α Subunits, Reduction of GABAA Receptor Binding, and Benzodiazepine-Resistant Anxiety , 2000, The Journal of Neuroscience.

[77]  J. Rapoport,et al.  Drug treatment of canine acral lick. An animal model of obsessive-compulsive disorder. , 1992, Archives of general psychiatry.

[78]  F. Graeff,et al.  Role of the amygdala and periaqueductal gray in anxiety and panic , 1993, Behavioural Brain Research.

[79]  Dan J Stein,et al.  NMDA receptor involvement in imipramine withdrawal-associated effects on swim stress, GABA levels and NMDA receptor binding in rat hippocampus. , 2002, Life sciences.

[80]  M. W. Andrews,et al.  Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[81]  J. Altmann,et al.  Hypercortisolism associated with social subordinance or social isolation among wild baboons. , 1997, Archives of general psychiatry.

[82]  A. Shekhar,et al.  Blockade of GABAA receptors in the region of the anterior basolateral amygdala of rats elicits increases in heart rate and blood pressure , 1991, Brain Research.

[83]  Elizabeth A. Hoge,et al.  Generalized Anxiety Disorder , 2004, Focus.

[84]  E. Kühn,et al.  Influence of exogenously administered oxytocin on prolactin release in the lactating rat. , 1973, Neuroendocrinology.

[85]  P. Martin Animal models sensitive to anti‐anxiety agents , 1998, Acta psychiatrica Scandinavica. Supplementum.

[86]  Hagit Cohen,et al.  The relevance of differential response to trauma in an animal model of posttraumatic stress disorder , 2003, Biological Psychiatry.

[87]  M. Liebowitz,et al.  Low dopamine D(2) receptor binding potential in social phobia. , 2000, The American journal of psychiatry.

[88]  S. Hogg A review of the validity and variability of the Elevated Plus-Maze as an animal model of anxiety , 1996, Pharmacology Biochemistry and Behavior.

[89]  G F Mason,et al.  Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments , 2002, Molecular Psychiatry.

[90]  D. Stein,et al.  Predictors of response to pharmacotherapy in social anxiety disorder: an analysis of 3 placebo-controlled paroxetine trials. , 2002, The Journal of clinical psychiatry.

[91]  J. Gorman,et al.  Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder. , 1997, Archives of general psychiatry.

[92]  P. G. Smelik,et al.  Site of action of dopamine and apomorphine on compulsive gnawing behaviour in rats , 1966, Experientia.

[93]  I. Liberzon,et al.  Summary of a National Institute of Mental Health workshop: developing animal models of anxiety disorders , 2001, Psychopharmacology.

[94]  W. Boyer Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta‐analysis , 1995, International clinical psychopharmacology.

[95]  Dan J Stein,et al.  Fluoxetine decreases stereotypic behavior in primates , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.